Literature DB >> 16186114

Maximal activation of skeletal muscle thin filaments requires both rigor myosin S1 and calcium.

David H Heeley1, Betty Belknap, Howard D White.   

Abstract

The regulation by calcium and rigor-bound myosin-S1 of the rate of acceleration of 2'-deoxy-3'-O-(N-methylanthraniloyl)ADP (mdADP) release from myosin-mdADP-P(i) by skeletal muscle thin filaments (reconstituted from actin-tropomyosin-troponin) was measured using double mixing stopped-flow fluorescence with the nucleotide substrate 2'-deoxy-3'-O-(N-methylanthraniloyl). The predominant mechanism of regulation is the acceleration of product dissociation by a factor of approximately 200 by thin filaments in the fully activated conformation (bound calcium and rigor S1) relative to the inhibited conformation (no bound calcium or rigor S1). In contrast, only 2-3-fold regulation is due to a change in actin affinity such as would be expected by "steric blocking" of the myosin binding site of the thin filament by tropomyosin. The binding of one ligand (either calcium or rigor-S1) produces partial activation of the rate of product dissociation, but the binding of both is required to maximally accelerate product dissociation to a rate similar to that obtained with F-actin in the absence of regulatory proteins. The data support an allosteric regulation model in which the binding of either calcium or rigor S1 alone to the thin filament shifts the equilibrium in favor of the active conformation, but full activation requires binding of both ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186114     DOI: 10.1074/jbc.M505549200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  The 3-state model of muscle regulation revisited: is a fourth state involved?

Authors:  Sherwin S Lehrer
Journal:  J Muscle Res Cell Motil       Date:  2011-09-25       Impact factor: 2.698

Review 2.  Disease causing mutations of troponin alter regulated actin state distributions.

Authors:  Joseph M Chalovich
Journal:  J Muscle Res Cell Motil       Date:  2012-06-08       Impact factor: 2.698

3.  Dual regulatory functions of the thin filament revealed by replacement of the troponin I inhibitory peptide with a linker.

Authors:  Julie Mouannes Kozaili; Daniel Leek; Larry S Tobacman
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

4.  Negative charges at protein kinase C sites of troponin I stabilize the inactive state of actin.

Authors:  Mohit C Mathur; Tomoyoshi Kobayashi; Joseph M Chalovich
Journal:  Biophys J       Date:  2007-09-14       Impact factor: 4.033

Review 5.  Cardiac thin filament regulation.

Authors:  Tomoyoshi Kobayashi; Lei Jin; Pieter P de Tombe
Journal:  Pflugers Arch       Date:  2008-04-18       Impact factor: 3.657

6.  Ca2+-induced movement of tropomyosin on native cardiac thin filaments revealed by cryoelectron microscopy.

Authors:  Cristina Risi; Jamie Eisner; Betty Belknap; David H Heeley; Howard D White; Gunnar F Schröder; Vitold E Galkin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

7.  Regulation of actin-myosin interaction by conserved periodic sites of tropomyosin.

Authors:  Bipasha Barua; Donald A Winkelmann; Howard D White; Sarah E Hitchcock-DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

8.  Hugh E. Huxley: the compleat biophysicist.

Authors:  Sarah E Hitchcock-DeGregori; Thomas C Irving
Journal:  Biophys J       Date:  2014-10-07       Impact factor: 4.033

9.  N-Terminal Domains of Cardiac Myosin Binding Protein C Cooperatively Activate the Thin Filament.

Authors:  Cristina Risi; Betty Belknap; Eva Forgacs-Lonart; Samantha P Harris; Gunnar F Schröder; Howard D White; Vitold E Galkin
Journal:  Structure       Date:  2018-09-27       Impact factor: 5.006

10.  Some cardiomyopathy-causing troponin I mutations stabilize a functional intermediate actin state.

Authors:  Mohit C Mathur; Tomoyoshi Kobayashi; Joseph M Chalovich
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.